Sinocelltech Ltd.

This study tests two experimental drugs (SCTB41 and SCTB39-1) given together, sometimes with standard cancer therapy, in adults with advanced solid tumors that have not responded to prior treatments. The goal is to find safe doses and see if the combination can shrink tumors or s…

This study tests a new drug, SCTB35, combined with lenalidomide for people with follicular lymphoma that has come back or not responded to prior treatment. The goal is to see if this new combination works better than the standard rituximab plus lenalidomide. About 93 adults aged …

This study tests a new medicine, SCTC21C, in 159 adults with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The goal is to see if the drug is safe and can reduce lupus symptoms. Participants must be on stable standard treatments and will receive the study drug …

This study tests whether a new drug called SCTB35, combined with standard chemotherapy, works better than the current standard treatment (rituximab plus chemo) for people whose diffuse large B-cell lymphoma has come back or stopped responding to prior therapy. About 101 adults ag…

This study tests whether adding the experimental drug SCTB41 to standard chemotherapy (docetaxel) can better control advanced non-small cell lung cancer that has worsened after prior treatment. About 90 adults with stage IIIB/IV disease will receive either the combo or a placebo …